Navigating the high costs of cancer care: opportunities for patient engagement

2021 ◽  
Author(s):  
Alexander H Gunn ◽  
Corinna Sorenson ◽  
Rachel A Greenup

Over the past decade, the financial burden of cancer care on patients and their families has garnered increased attention. Many of the potential solutions have focused on system-level interventions such as adopting value-based payment models and negotiating drug prices; less consideration has been given to actions at the patient level to address cancer care costs. We argue that it is imperative to develop and support patient-level strategies that engage patients and consider their preferences, values and individual circumstances. Opportunities to meet these aims and improve the economic experience of patients in oncology are discussed, including: shared decision-making and communication, financial navigation and treatment planning, digital technology and alternative care pathways, and value-based insurance design.

Author(s):  
Ryan D. Nipp ◽  
Ellen Miller Sonet ◽  
Gery P. Guy

In recent years, high health care costs and the financial burden of cancer care have received increased attention. In response to the financial burden of cancer care, patients may jeopardize their health outcomes by not properly adhering to prescribed therapies or even forgoing and delaying care in an effort to defray costs. In addition, the financial burden experienced by patients with cancer may negatively impact clinical outcomes, such as quality of life, physical and psychological symptoms, and potentially, even survival. Notably, in the current era of targeted treatment and immunotherapies for patients with cancer, the rising costs of cancer continue to remain at the forefront of patient concerns. Therefore, a critical need exists to determine how best to assist patients with the cost burden of cancer diagnosis and treatment


2014 ◽  
Vol 10 (5) ◽  
pp. 332-338 ◽  
Author(s):  
Kathleen M. Fenn ◽  
Suzanne B. Evans ◽  
Ruth McCorkle ◽  
Michael P. DiGiovanna ◽  
Lajos Pusztai ◽  
...  

Increased financial burden as a result of cancer care costs is the strongest independent predictor of poor quality of life among cancer survivors.


Author(s):  
S. Yousuf Zafar ◽  
Lee N. Newcomer ◽  
Justin McCarthy ◽  
Shelley Fuld Nasso ◽  
Leonard B. Saltz

The median price of a month of chemotherapy has increased by an order of magnitude during the past 20 years, far exceeding inflation over the same period. Along with rising prices, increases in cost sharing have forced patients to directly shoulder a greater portion of those costs, resulting in undue financial burden and, in some cases, cost-related nonadherence to treatment. What can we do to intervene on treatment-related financial toxicity of patients? No one party can single-handedly solve the problem, and the solution must be multifaceted and creative. A productive discussion of the problem must avoid casting blame and, instead, must look inward for concrete starting points toward improvement in the affordability and value of cancer care. With these points in mind, the authors—representatives from the pharmaceutical industry, insurance providers, oncologists, and patient advocacy—have each been asked to respond with a practical answer to the provocative hypothetical question, “If you could propose one thing, and one thing only, in terms of an action or change by the constituency you represent in this discussion, what would that be?”


2016 ◽  
Vol 21 (4) ◽  
pp. 467-474 ◽  
Author(s):  
Ryan D. Nipp ◽  
Hang Lee ◽  
Elizabeth Powell ◽  
Nicole E. Birrer ◽  
Emily Poles ◽  
...  

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. e18056-e18056
Author(s):  
Emily Poles ◽  
Ryan David Nipp ◽  
Elyse R. Park ◽  
Bruce Allan Chabner ◽  
Beverly Moy

Sign in / Sign up

Export Citation Format

Share Document